Delisting riskPopularity #5,339
Functional Brands (MEHA)
Manufactures Kirkman supplements and extends them into prenatal and telehealth wellness offerings.
$0.0048
At close+0.00 (+2.13%)
In millions of USD, except per-share figures
| In millions | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 2 |
| Cost of revenue | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Gross profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |
| 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 |
| Operating income | 0 | 0 | 0 | 0 | 0 | 0 | −1 | −1 | −1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 2 | −6 | −1 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 0 | 0 | 0 | 0 | 0 | 0 | 1 | −7 | −3 |
| Net income from continuing operations | 0 | 0 | 0 | 0 | 0 | 0 | 1 | −7 | −3 |
| Net income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | −7 | −3 |
| EPS, basic | −$0.01 | −$0.04 | −$0.04 | −$0.02 | −$0.03 | $0.04 | $0.09 | −$0.85 | −$0.06 |
| EPS, diluted | −$0.01 | −$0.04 | −$0.04 | −$0.02 | −$0.03 | $0.04 | $0.01 | −$0.08 | −$0.06 |
| Weighted average shares, basic | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 43 |
| Weighted average shares, diluted | 7 | 7 | 7 | 7 | 7 | 7 | 85 | 85 | 43 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | −1 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| EBIT | 0 | 0 | 0 | 0 | 0 | 0 | −1 | −1 | −1 |